George Scangos '70, CEO of Biogen, one of the most valuable biotech companies in the country, discussed balancing the needs of Wall Street and patients during his lecture as the Robert S. Hatfield Fellow in Economic Education.
Cornell biomedical engineers have developed specialized white blood cells – dubbed "super natural killer cells" – that seek out cancer cells in lymph nodes with only one purpose: destroy them.
As many as one out of 10 people age 60 and older will experience some kind of abuse, most often in the form of financial exploitation, says a new Cornell study.
Three pairs of early career scientists have been named the inaugural Mong Family Foundation Fellows in Neurotech. They will work jointly under the mentorship of faculty across Cornell to advance brain technologies.
To advance a powerful cancer treatment strategy that uses immune cells to fight the disease, Ellen and Gary Davis '76 have made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy.
The Cornell Institute for Food Systems Industry Partnership Program offers a new public-private partnership that brings together Cornell’s food science faculty and staff with industry scientists, engineers and leaders.
Dr. Arjun Srinivasan of the CDC delivered the keynote lecture at the symposium, "Antimicrobial Resistance: Research Synergies in Human and Animal Medicine," on Cornell's Ithaca campus May 4.
Boyce Thompson Institute are working to apply a method that boosts beta-carotene into in potatoes to cassava plants. Biofortified cassava could help alleviate vitamin A deficiency in children.
In the war against MRSA, constructing single-patient rooms – rather than sick-bay style, multi-patient rooms – reduces hospital-acquired infections among patients, says new Cornell-led study.
Two Weill Cornell Medicine faculty members, Dr. Francis Lee and Dr. Jane Salmon, were elected to National Academy of Medicine, it was announced Oct. 17.